115 related articles for article (PubMed ID: 9458851)
1. Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo.
Devlin AM; Brosnan MJ; Graham D; Morton JJ; McPhaden AR; McIntyre M; Hamilton CA; Reid JL; Dominiczak AF
Am J Physiol; 1998 Jan; 274(1):H52-9. PubMed ID: 9458851
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in the abundance of endothelial nitric oxide in a model of genetic hypertension.
McIntyre M; Hamilton CA; Rees DD; Reid JL; Dominiczak AF
Hypertension; 1997 Dec; 30(6):1517-24. PubMed ID: 9403576
[TBL] [Abstract][Full Text] [Related]
3. Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid.
Ajay M; Achike FI; Mustafa MR
Pharmacol Res; 2007 May; 55(5):385-91. PubMed ID: 17317209
[TBL] [Abstract][Full Text] [Related]
4. Chronic inhibition of nitric-oxide synthase potentiates endothelium-dependent contractions in the rat aorta by augmenting the expression of cyclooxygenase-2.
Qu C; Leung SW; Vanhoutte PM; Man RY
J Pharmacol Exp Ther; 2010 Aug; 334(2):373-80. PubMed ID: 20444882
[TBL] [Abstract][Full Text] [Related]
5. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
[TBL] [Abstract][Full Text] [Related]
6. Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
Dominiczak AF; Devlin AM; Lee WK; Anderson NH; Bohr DF; Reid JL
Hypertension; 1996 Mar; 27(3 Pt 2):752-9. PubMed ID: 8613236
[TBL] [Abstract][Full Text] [Related]
7. Structural changes in cerebral arteries following nitric oxide deprivation: a comparison between normotensive and hypertensive rats.
Hsieh NK; Wang JY; Liu JC; Lee WH; Chen HI
Thromb Haemost; 2004 Jul; 92(1):162-70. PubMed ID: 15213857
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats.
McKendrick JD; Salas E; Dubé GP; Murat J; Russell JC; Radomski MW
Br J Pharmacol; 1998 May; 124(2):361-9. PubMed ID: 9641554
[TBL] [Abstract][Full Text] [Related]
9. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats.
Numaguchi K; Egashira K; Takemoto M; Kadokami T; Shimokawa H; Sueishi K; Takeshita A
Hypertension; 1995 Dec; 26(6 Pt 1):957-62. PubMed ID: 7490155
[TBL] [Abstract][Full Text] [Related]
10. Effects of aminoguanidine and N(omega)-nitro-L-arginine methyl ester on vascular hyporeactivity induced by endotoxaemia.
Ismailoglu UB; Pekiner C; Yorganci K; Sahin-Erdemli I
Eur J Surg; 2001 Nov; 167(11):803-9. PubMed ID: 11848232
[TBL] [Abstract][Full Text] [Related]
11. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
[TBL] [Abstract][Full Text] [Related]
12. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor.
de Oliveira CF; Cintra KA; Teixeira SA; De Luca IM; Antunes E; De Nucci G
Eur J Pharmacol; 2000 Mar; 391(1-2):121-6. PubMed ID: 10720643
[TBL] [Abstract][Full Text] [Related]
13. Chronic low-dose L-NAME treatment effect on cardiovascular system of borderline hypertensive rats: feedback regulation?
Kopincova J; Puzserova A; Bernatova I
Neuro Endocrinol Lett; 2008 Oct; 29(5):784-9. PubMed ID: 18987608
[TBL] [Abstract][Full Text] [Related]
14. In vitro alteration of aortic vascular reactivity in hypertension induced by chronic NG-nitro-L-arginine methyl ester.
Henrion D; Dowell FJ; Levy BI; Michel JB
Hypertension; 1996 Sep; 28(3):361-6. PubMed ID: 8794817
[TBL] [Abstract][Full Text] [Related]
15. Failure of L-nitroarginine to inhibit the activity of aortic inducible nitric oxide synthase.
Darblade B; Batkai S; Caussé E; Gourdy P; Fouque MJ; Rami J; Arnal JF
J Vasc Res; 2001; 38(3):266-75. PubMed ID: 11399899
[TBL] [Abstract][Full Text] [Related]
16. Effects induced by inhibitors of the phosphatidylinositol 3-kinase/Akt and nitric oxide synthase/guanylyl cyclase pathways on the isometric contraction in rat aorta: a comparative study.
López RM; Pérez T; Castillo C; Castillo EF
Fundam Clin Pharmacol; 2011 Jun; 25(3):313-22. PubMed ID: 20584208
[TBL] [Abstract][Full Text] [Related]
17. Hypertensive effects of oral administration of the aqueous extract of Solanum torvum fruits in L-NAME treated rats: evidence from in vivo and in vitro studies.
Nguelefack TB; Mekhfi H; Dongmo AB; Dimo T; Watcho P; Zoheir J; Legssyer A; Kamanyi A; Ziyyat A
J Ethnopharmacol; 2009 Jul; 124(3):592-9. PubMed ID: 19439171
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic inhibition of nitric oxide on hypertension, insulin resistance, and cardiovascular remodeling in glucose-fed rats.
Pilon M; Wu R; Huot-Marchand JE; deBlois D; Champlain Jd; Couture R
J Cardiovasc Pharmacol; 2009 May; 53(5):405-13. PubMed ID: 19333132
[TBL] [Abstract][Full Text] [Related]
19. Direct effects of quercetin on impaired reactivity of spontaneously hypertensive rat aortae: comparative study with ascorbic acid.
Ajay M; Achike FI; Mustafa AM; Mustafa MR
Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):345-50. PubMed ID: 16620299
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nitric oxide in rats. Regulation of cardiovascular structure and expression of insulin-like growth factor I and its receptor messenger RNA.
Wickman A; Isgaard J; Adams MA; Friberg P
J Hypertens; 1997 Jul; 15(7):751-9. PubMed ID: 9222943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
